当前位置: 首页 > 期刊 > 《医学信息》 > 2016年第26期
编号:12961764
肿瘤类疾病风险与谷胱甘肽转硫酶T1基因多态性的关系(3)
http://www.100md.com 2016年7月2日 《医学信息》 2016年第26期
     [22]He HR, Zhang XX, Sun JY, et al. Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia [J].Tumour Biol, 2014, 35(6): 6119-6125.

    [23]Bin Q, Luo J. Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin and non-Hodgkin lymphoma risk: a Human Genome Epidemiology (HuGE) review [J].Leuk Lymphoma, 2013, 54(1): 14-20.

    [24]Fang M, Zeng W, Huang L, et al. Association between glutathione S-transferase T1 null genotype and risk of myelodysplastic syndromes: a comprehensive meta-analysis [J].Tumour Biol, 2013, 34(5): 2747-2752.

    [25]Yang H, Shen X, Li B, et al. Association between glutathione S-transferase T1 null genotype and risk of lung cancer: a meta-analysis of 55 studies [J].Tumour Biol, 2014, 35(3): 2359-2366.

    [26]Wang Z, Xu H, He M, et al. The association of glutathione S-transferase polymorphisms in patients with osteosarcoma: evidence from a meta-analysis[J].Eur J Cancer Care (Engl), 2014:

    [27]Nie F, Chen Z, Cao C, et al. Absence of association between GSTM1 and GSTT1 polymorphisms and melanoma susceptibility: a meta-analysis [J].DNA Cell Biol, 2011, 30(10): 783-788.

    编辑/翟辰万, http://www.100md.com(王丹 刘殿武 翟俊霞)
上一页1 2 3